Carmot Therapeutics was a clinical-stage biotech developing GLP-1-based therapeutics for obesity and metabolic diseases; acquired by Roche in 2024.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
